Stay updated on Pediatric Fremanezumab for Episodic Migraine Clinical Trial
Sign up to get notified when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.

Latest updates to the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedThe ClinicalTrials.gov site revision shown in the footer changed from v3.7.0 to v3.7.1.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedA new latest revision label, v3.7.0, has been added to the record history, while the previous label v3.6.6 has been removed.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays the latest revision label 'Revision: v3.6.6', replacing the previous 'Revision: v3.6.5'. This reflects an update to the page's release/version information in the history view.SummaryDifference0.0%

- Check68 days agoChange DetectedFooter now displays Revision: v3.6.5, replacing Revision: v3.6.4. This indicates a software version update rather than any change to study data or page content.SummaryDifference0.0%

- Check82 days agoChange DetectedThe page history now lists Revision: v3.6.4, replacing v3.6.3, which represents a platform-level update. This change does not affect study data or user-facing content.SummaryDifference0.0%

- Check104 days agoChange DetectedA new Revision: v3.6.3 entry was added to the study history. The previous Revision: v3.6.2 entry was removed.SummaryDifference0.0%

Stay in the know with updates to Pediatric Fremanezumab for Episodic Migraine Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Pediatric Fremanezumab for Episodic Migraine Clinical Trial page.